MCID: NRG002
MIFTS: 50

Neurogenic Bladder malady

Categories: Neuronal diseases, Nephrological diseases

Aliases & Classifications for Neurogenic Bladder

About this section

Aliases & Descriptions for Neurogenic Bladder:

Name: Neurogenic Bladder 11 27 13
Neurogenic Dysfunction of the Urinary Bladder 11
Neurogenic Urinary Bladder Disorder 11
Urinary Bladder, Neurogenic 39
 
Neurogenic Urinary Bladder 68
Neuropathic Bladder 11
Bladder Neurogenic 50

Classifications:



External Ids:

Disease Ontology11 DOID:12143
ICD9CM32 596.54
MeSH39 D001750
NCIt45 C79696

Summaries for Neurogenic Bladder

About this section
Wikipedia:71 Neurogenic bladder dysfunction, sometimes simply referred to as neurogenic bladder, is a dysfunction of... more...

MalaCards based summary: Neurogenic Bladder, also known as neurogenic dysfunction of the urinary bladder, is related to brain injury and hinman syndrome, and has symptoms including dysuria, dysuria and meningism. An important gene associated with Neurogenic Bladder is HPSE2 (Heparanase 2 (Inactive)), and among its related pathways are Arf6 trafficking events and Calcium signaling pathway. The drugs oxybutynin and hyoscyamine hydrobromide have been mentioned in the context of this disorder. Affiliated tissues include spinal cord, testes and prostate, and related mouse phenotypes are cardiovascular system and nervous system.

Related Diseases for Neurogenic Bladder

About this section

Diseases related to Neurogenic Bladder via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 74)
idRelated DiseaseScoreTop Affiliating Genes
1brain injury29.2P2RX2, UPK3A
2hinman syndrome11.4
3urofacial syndrome 111.1
4polyglucosan body disease, adult form11.0
5adult polyglucosan body disease11.0
6lethal congenital contractural syndrome 210.9
7lethal congenital contractural syndrome 310.9
8spinal cord injury10.4
9vesicoureteral reflux10.2
10myelomeningocele10.2
11bacteriuria10.2
12bladder disease10.1
13urethritis10.1
14prostatitis10.0
15cystitis9.9
16cone-rod dystrophy 159.9HPSE2, LRIG2
17cerebritis9.9
18herpes zoster9.9
19cerebral palsy9.8
20cervicitis9.8
21spasticity9.8
22lymphocytic choriomeningitis9.8MEOX2, P2RX1, P2RX2
23fuchs' heterochromic uveitis9.8KIDINS220, UPK3A
24systemic lupus erythematosus9.7
25prostatic hypertrophy9.7
26pyelonephritis9.7
27bladder neck obstruction9.7
28interstitial cystitis9.7
29perinephritis9.7
30kidney disease9.7
31lupus erythematosus9.7
32multiple myeloma9.6
33end stage renal failure9.6
34hereditary spastic paraplegia9.6
35pol iii-related leukodystrophies9.6
36sacrococcygeal teratoma9.6
37rocky mountain spotted fever9.6
38lambert-eaton myasthenic syndrome9.6
39latex allergy9.6
40spina bifida occulta9.6
41endocarditis9.6
42leukodystrophy9.6
43tethered spinal cord syndrome9.6
44spotted fever9.6
45lyme disease9.6
46detrusor sphincter dyssynergia9.6
47arachnoiditis9.6
48neurogenic bowel9.6
49prostate calculus9.6
50down syndrome9.6

Comorbidity relations with Neurogenic Bladder via Phenotypic Disease Network (PDN):

(show all 30)
Active Peptic Ulcer DiseaseAcute Cystitis
Acute Kidney FailureAlzheimer Disease
Bladder Neck ObstructionChronic Kidney Failure
Chronic Myocardial IschemiaCystitis
Deficiency AnemiaDiabetic Polyneuropathy
Familial Atrial FibrillationHeart Disease
HydronephrosisHypertension, Essential
HypothyroidismIschemic Heart Disease
Multiple Sclerosis, Disease Progression, Modifier ofDecubitus Ulcer
Epilepsy, Focal, with Speech Disorder and with or Without Mental RetardationOsteoporosis
Prostatic HypertrophySwallowing Disorders
Urethral StrictureParalytic Ileus
ParaplegiaParkinson Disease, Late-Onset
Peripheral Vascular DiseaseProtein-Energy Malnutrition
Schizophreniform DisorderTransient Cerebral Ischemia

Graphical network of the top 20 diseases related to Neurogenic Bladder:



Diseases related to neurogenic bladder

Symptoms & Phenotypes for Neurogenic Bladder

About this section

UMLS symptoms related to Neurogenic Bladder:


dysuria, meningism, pain, paresis, reflex, abnormal, seizures, vertigo, neurobehavioral manifestations, neuromuscular manifestations

MGI Mouse Phenotypes related to Neurogenic Bladder according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053858.1CHRM2, GBE1, KIDINS220, MEOX2, P2RX1, P2RX2
2MP:00036317.3CHRM2, GBE1, KIDINS220, LRIG2, MEOX2, P2RX2

Drugs & Therapeutics for Neurogenic Bladder

About this section

Drugs for Neurogenic Bladder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 112)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
SulfamethoxazoleapprovedPhase 4, Phase 1, Phase 2161723-46-65329
Synonyms:
129378-89-8
3-(Para-Aminophenylsulphonamido)-5-methylisoxazole
3-(p-Aminobenzenesulfonamido)-5-methylisoxazole
3-(p-Aminophenylsulfonamido)-5-methylisoxazole
3-(para-Aminophenylsulphonamido)-5-methylisoxazole
3-Sulfanilamido-5-methylisoxazole
3-Sulphanilamido-5-methylisoxazole
4-Amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide
4-Amino-N-(5-methyl-3-isoxazolyl)-Benzenesulfonamide
4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide
4-Amino-N-(5-methyl-isoxazol-3-yl)-benzenesulfonamide
4-Amino-N-[5-methyl-3- isoxazolyl]benzenesulfonamide
4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide
4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide
46850_RIEDEL
5-Methyl-3-sulfanilamidoisoxazole
5-Methyl-3-sulfanylamidoisoxazole
5-Methyl-3-sulfonylamidoisoxazole
5-Methyl-3-sulphanil-amidoisoxazole
723-46-6
A047
AB00052099
AC-11118
AC1L1K42
AC1Q2J5R
AKOS000200952
ALBB-002089
ARONIS018156
Apo-Sulfamethoxazole
Azo Gantanol
Azo-Gantanol
Azo-gantanol
BAS 00836086
BB_SC-1251
BIDD:GT0731
BPBio1_000081
BRD-K28494619-001-05-0
BRN 0226453
BSPBio_000073
BSPBio_002028
Bactrim
Bactrimel
C07315
C10H11N3O3S
CAS-723-46-6
CCRIS 567
CHEBI:9332
CHEMBL443
CID5329
CPD000058223
D00447
D013420
DB01015
DivK1c_000649
EINECS 211-963-3
Gamazole
Gantanol
Gantanol (TN)
Gantanol (tn)
Gantanol-DS
HMS1568D15
HMS1921A21
HMS2092K03
HMS502A11
HMS561O18
HSDB 3186
I01-0154
IDI1_000649
InChI=1/C10H11N3O3S/c1-7-6-10(12-16-7)13-17(14,15)9-4-2-8(11)3-5-9/h2-6H,11H2,1H3,(H,12,13)
KBio1_000649
KBio2_001474
KBio2_004042
KBio2_006610
KBio3_001528
KBioGR_000749
KBioSS_001474
LS-1620
MLS000069732
MLS001055354
MLS001074165
MS 53
Maybridge1_007190
Metoxal
MolPort-000-145-787
N'-(5-Methyl-3-isoxazole)sulfanilamide
 
N'-(5-Methyl-3-isoxazolyl)-Sulfanilamide
N'-(5-Methyl-3-isoxazolyl)sulfanilamide
N'-(5-Methylisoxazol-3-yl)sulphanilamide
N(Sup1)-(5-Methyl-3-isoxazolyl)sulfanilamide
N(sup 1)-(5-Methyl-3-isoxazolyl)sulfanilamide
N(sup 1)-(5-Methyl-3-isoxazolyl)sulphanilamide
N(sup1)-(5-Methyl-3-isoxazolyl)sulfanilamide
N1-(5-Methyl-3-isoxazolyl)sulfanilamide
N1-(5-Methyl-3-isoxazolyl)sulphanilamide
N1-(5-Methylisoxazol-3-yl)sulfanilamide
N1-(5-methyl-3-isoxazolyl)-Sulfanilamide
NCGC00016533-01
NCGC00016533-02
NCGC00021995-03
NCGC00021995-04
NCGC00021995-05
NINDS_000649
NSC 147832
NSC147832
N^1-(5-Methyl-3-isoxazolyl)-Sulfanilamide
Ndimethyl1-(5-methyl-3-isoxazolyl)-Sulfanilamide
Oprea1_114486
Oprea1_285680
Prestwick0_000177
Prestwick1_000177
Prestwick2_000177
Prestwick3_000177
Prestwick_453
Radonil
Ro 4-2130
Ro 6-2580/11
Ro-4-2130
S0361
S1915_Selleck
S7507_FLUKA
S7507_SIGMA
SAM002554930
SIM
SMR000058223
SMX
SPBio_000896
SPBio_001994
SPECTRUM1500550
STK007988
SULFAMETHOXAZOLE (8064-90-2 (TRIMETHOPRIM/SULFAMETHOXAZOLE)
Septran
Simsinomin
Sinomin
Solfametossazolo
Solfametossazolo [DCIT]
Spectrum2_000788
Spectrum3_000584
Spectrum4_000345
Spectrum5_000982
Spectrum_000994
Sulfamethalazole
Sulfamethoxazol
Sulfamethoxazole
Sulfamethoxazole (JP15/USP/INN)
Sulfamethoxazole [USAN:INN:JAN]
Sulfamethoxazole sodium
Sulfamethoxazole(USAN)
Sulfamethoxazolum
Sulfamethoxazolum [INN-Latin]
Sulfamethoxizole
Sulfamethylisoxazole
Sulfametoxazol
Sulfametoxazol [INN-Spanish]
Sulfanilamide, N1-(5-methyl-3-isoxazolyl)- (8CI)
Sulfisomezole
Sulpha-Methoxizole
Sulpha-methoxizole
Sulphamethalazole
Sulphamethoxazol
Sulphamethoxazole
Sulphamethoxazole BP 98
Sulphamethylisoxazole
Sulphisomezole
TL8005058
TMP/SMX (MIXTURE))
Trib
UNII-JE42381TNV
Urobak
WLN: T5NOJ C1 EMSWR DZ
ZINC00089763
nchembio.221-comp24
sulfamethoxazole
2
Oxybutyninapproved, investigationalPhase 4, Phase 3685633-20-54634
Synonyms:
1508-65-2 (hydrochloride)
4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester
4-(diethylamino)-2-butynyl-alpha-cyclohexyl-alpha-hydroxybenzeneacetate
4-(diethylamino)-2-butynyl-alpha-phenylcyclohexaneglycolate
4-(diethylamino)but-2-yn-1-yl cyclohexyl(hydroxy)phenylacetate
4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate
4-Diethylamino-2-butinyl alpha-cyclohexylmandelat
4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate
5633-20-5
AC-2153
AC1L1ILV
BPBio1_000214
BRD-A65013509-003-03-8
BSPBio_000194
Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester
C07360
CCRIS 1923
CHEBI:7856
CHEMBL1231
CID4634
Cyclohexaneglycolic acid, .alpha.-phenyl-, 4-(diethylamino)-2-butynyl ester
Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester
Cystrin
D00465
DB01062
Ditropan
Ditropan, Lyrinel XL, Oxytrol, Oxybutynin
FT-0082890
HSDB 3270
I06-2117
L000923
LS-28714
 
Lopac0_000923
MolPort-003-849-741
NCGC00015767-06
NCGC00089795-02
Oxibutinina
Oxibutinina [INN-Spanish]
Oxibutyninum
Oxybutinin
Oxybutynin
Oxybutynin (USAN/INN)
Oxybutynin Base
Oxybutynin Chloride
Oxybutynin Hydrochloride
Oxybutynin [USAN:INN:BAN]
Oxybutynin topical gel
Oxybutynine
Oxybutynine [INN-French]
Oxybutyninum
Oxybutyninum [INN-Latin]
Oxytrol
Oxytrol (TN)
Pollakisu
Prestwick0_000287
Prestwick1_000287
Prestwick2_000287
Prestwick3_000287
S1754_Selleck
SPBio_002413
Transdermal patch
UNII-K9P6MC7092
oxybutynin
oxybutynin topical gel
transdermal patch
3
Lidocaineapproved, vet_approvedPhase 41317137-58-63676
Synonyms:
.alpha.-(Diethylamino)-2,6-acetoxylidide
.alpha.-Diethylamino-2,6-dimethylacetanilide
.alpha.-Diethylaminoaceto-2,6-xylidide
.omega.-Diethylamino-2,6-dimethylacetanilide
137-58-6
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide
4-12-00-02538 (Beilstein Handbook Reference)
6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))
6108-05-0 (mono-hydrochloride, mono-hydrate)
73-78-9 (mono-hydrochloride)
AB00053581
AC-10282
AC1L1GGQ
AC1Q2Z7J
AKOS001026768
ARONIS23855
After Burn Double Strength Gel
After Burn Double Strength Spray
After Burn Gel
After Burn Spray
Alphacaine
Anestacon
Anestacon Jelly
BIDD:GT0342
BPBio1_000197
BRD-K52662033-001-02-6
BRD-K52662033-003-05-5
BRN 2215784
BSPBio_000179
BSPBio_001359
BSPBio_003004
Bio-0767
Bio1_000379
Bio1_000868
Bio1_001357
Bio2_000079
Bio2_000559
C07073
C14H22N2O
CAS-73-78-9
CDS1_000283
CHEBI:6456
CHEMBL79
CID3676
CPD000058189
Cappicaine
Cito optadren
Cuivasil
D00358
DB00281
Dalcaine
Dentipatch
Dentipatch (TN)
DermaFlex
Diethylaminoaceto-2,6-xylidide
Dilocaine
DivK1c_000174
DivK1c_001323
Duncaine
EINECS 205-302-8
ELA-Max
EMBOLEX
Emla
Emla Cream
Esracaine
FT-0082378
Gravocain
HMS1791D21
HMS1989D21
HMS2051C21
HMS2089E15
HMS548M19
HSDB 3350
I01-2704
IDI1_000174
IDI1_033829
Isicaina
Isicaine
Jetocaine
KBio1_000174
KBio2_000079
KBio2_001598
KBio2_002647
KBio2_004166
KBio2_005215
KBio2_006734
KBio3_000157
KBio3_000158
KBio3_002224
KBioGR_000079
KBioGR_000599
KBioSS_000079
KBioSS_001598
L-Caine
L0156
L1026_SIGMA
L7757_SIGMA
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)
LIDOPEN
LQZ
 
LS-805
Lanabiotic
Leostesin
Lida-Mantle
Lidocaina
Lidocaina [INN-Spanish]
Lidocaine (JP15/USP/INN)
Lidocaine (VAN)
Lidocaine Carbonate
Lidocaine Hydrocarbonate
Lidocaine Monohydrochloride
Lidocaine [USAN:INN:JAN]
Lidocainum
Lidocainum [INN-Latin]
Lidocaton
Lidoderm
Lidoject-1
Lidoject-2
Lignocaine
Lignocainum
Lingocaine
Lopac-L-5647
Lopac0_000669
MLS000069724
MLS000758263
MLS001074177
Maricaine
Maybridge1_002571
MolPort-001-783-478
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide
NCGC00015611-01
NCGC00015611-02
NCGC00015611-03
NCGC00015611-04
NCGC00015611-14
NCGC00022176-05
NCGC00022176-06
NCGC00022176-07
NCGC00022176-08
NCGC00022176-09
NINDS_000174
NSC 40030
NSC40030
Norwood Sunburn Spray
Octocaine
Octocaine-100
Octocaine-50
Prestwick0_000050
Prestwick1_000050
Prestwick2_000050
Prestwick3_000050
Remicaine
Rocephin Kit
Rucaina
S1357_Selleck
SAM001247018
SMR000058189
SPBio_001525
SPBio_002100
STK552033
Solarcaine
Solarcaine aloe extra burn relief cream
Solcain
Spectrum2_001343
Spectrum3_001392
Spectrum4_000070
Spectrum5_001549
Spectrum_001118
UNII-98PI200987
WLN: 2N2 & 1VMR B1 F1
Xilina
Xilocaina
Xilocaina [Italian]
Xllina
Xycaine
Xylestesin
Xylesthesin
Xylocain
Xylocaine
Xylocaine (TN)
Xylocaine 5% Spinal
Xylocaine CO2
Xylocaine Dental Ointment
Xylocaine Endotracheal
Xylocaine Test Dose
Xylocaine Viscous
Xylocaine-MPF
Xylocaine-MPF with Glucose
Xylocaine-Mpf
Xylocaine-Mpf with Glucose
Xylocard
Xylocitin
Xyloneural (free base)
Xylotox
Zilactin-L
Zingo
alfa-Dietilamino-2,6-dimetilacetanilide
alfa-Dietilamino-2,6-dimetilacetanilide [Italian]
alpha-Diethylamino-2,6-dimethylacetanilide
alpha-diethylamino-2,6-dimethylacetanilide
lidocaine
nchembio.65-comp16
α-diethylamino-2,6-dimethylacetanilide
4
Trimethoprimapproved, vet_approvedPhase 4, Phase 1, Phase 2177738-70-55578
Synonyms:
2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine
46984_FLUKA
46984_RIEDEL
5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine
738-70-5
92131_FLUKA
92131_SIGMA
AB00052118
AB1004879
AC-13572
AC1L1KNQ
AC1Q48DF
AI3-52594
AKOS001650069
ARONIS24118
AZT + TMP/SMX (mixture) combination
Abacin
Abaprim
Alcorim-F
Alprim
Anitrim
Antrima
Antrimox
Apo-Sulfatrim
BB_SC-2116
BIDD:GT0190
BPBio1_000215
BRD-K07208025-001-06-5
BRN 0625127
BSPBio_000195
BSPBio_002245
BW 56-72
BW 5672
BW-56-72
Bacdan
Bacidal
Bacide
Bacin
Bacta
Bacterial
Bacterial [Antibiotic]
Bacticel
Bactin
Bactoprim
Bactramin
Bactrim
Bactrim DS
Bactrim Pediatric
Baktar
Bencole
Bethaprim
Biosulten
Briscotrim
C01965
CAS-738-70-5
CCRIS 2410
CHEBI:45924
CHEMBL22
CID5578
CPD0-1581
CPD000035999
Chemotrim
Chemotrin
Cidal
Co-Trimoxizole
Co-trimoxazole
Colizole
Colizole DS
Comox
Conprim
Cotrim
Cotrim D.S.
Cotrimel
D00145
D014295
DB00440
Deprim
DivK1c_000589
Drylin
Duocide
EINECS 212-006-2
EU-0101271
Esbesul
Espectrin
Euctrim
Eusaprim
Exbesul
Fectrim
Fermagex
Fortrim
Futin
Gantaprim
Gantrim
HMS1568J17
HMS1921I03
HMS2090D14
HMS2092A10
HMS501N11
HSDB 6781
I06-0086
IDI1_000589
Idotrim
Ikaprim
Imexim
Instalac
Ipral
KBio1_000589
KBio2_000647
KBio2_003215
KBio2_005783
KBio3_001465
KBioGR_000863
KBioSS_000647
KSC-4-158
KUC103659N
Kepinol
Kombinax
LS-1627
Lagatrim
Lagatrim Forte
Laratrim
Lastrim
Lidaprim
Linaris
Lopac-T-7883
Lopac0_001271
MLS000079023
MLS001201740
MLS002303068
Methoprim
Metoprim
Microtrim
MolPort-001-826-685
Monoprim
Monotrim
Monotrimin
NCGC00016055-01
NCGC00016055-02
NCGC00016055-06
NCGC00016055-12
NCGC00024707-01
NCGC00024707-03
NCGC00024707-04
NCGC00024707-05
NCGC00024707-06
NCGC00024707-07
NCGC00024707-08
NIH 204
 
NIH 204 (VAN)
NINDS_000589
NSC 106568
NSC-106568
NSC106568
Nopil
Novotrimel
Omstat
Oprea1_495058
Oraprim
Pancidim
Polytrim
Prestwick0_000208
Prestwick1_000208
Prestwick2_000208
Prestwick3_000208
Prestwick_485
Priloprim
Primosept
Primsol
Proloprim
Proloprim (TN)
Protrin
Purbal
Resprim
Resprim Forte
Roubac
Roubal
SAM002264649
SMP2_000262
SMR000035999
SPBio_000874
SPBio_002116
SPECTRUM1500595
STK177322
Salvatrim
Septra
Septra DS
Septra Grape
Septrin
Septrin DS
Septrin Forte
Septrin S
Setprin
Sigaprim
Sinotrim
Smz-Tmp
Spectrum2_000937
Spectrum3_000643
Spectrum4_000372
Spectrum5_001559
Spectrum_000167
Stopan
Streptoplus
Sugaprim
Sulfamar
Sulfamethoprim
Sulfamethoprim-DS
Sulfamethoxazole & Trimethoprim
Sulfatrim
Sulfatrim Pediatric
Sulfatrim-DS
Sulfatrim-SS
Sulfotrim
Sulfoxaprim
Sulmeprim
Sulmeprim Pediatric
Sulprim
Sulthrim
Sultrex
Sumetrolim
Supracombin
Suprim
Syraprim
T 7883
T2286
T7883_SIGMA
TCMDC-125538
TL8005108
TMP/SMX (MIXTURE))
Teleprim
Thiocuran
Tiempe
Tmp-Ratiopharm
Tocris-0650
Toprim
Trigonyl
Trimanyl
Trimesulf
Trimeth/Sulfa
Trimethioprim
Trimethopim(TMP)
Trimethoprim
Trimethoprim & VRC3375
Trimethoprim (JAN/USP/INN)
Trimethoprim [USAN:BAN:INN:JAN]
Trimethoprime
Trimethoprime [INN-French]
Trimethoprimum
Trimethoprimum [INN-Latin]
Trimethopriom
Trimetoprim
Trimetoprim [DCIT]
Trimetoprim [Polish]
Trimetoprima
Trimetoprima [INN-Spanish]
Trimexazole
Trimexol
Trimez-IFSA
Trimezol
Trimogal
Trimono
Trimopan
Trimpex
Trimpex (TN)
Trimpex 200
Triméthoprime
Triprim
Trisul
Trisulcom
Trisulfam
Trisural
U-Prin
UNII-AN164J8Y0X
UPCMLD-DP132
UPCMLD-DP132:001
Unitrim
Uretrim
Uro-D S
Uro-Septra
Urobactrim
Uroplus
Uroplus DS
Uroplus SS
Utetrin
Velaten
WLN: T6N CNJ BZ DZ E1R CO1 DO1 EO1
WR 5949
Wellcoprim
Wellcoprin
Xeroprim
ZINC06627681
Zamboprim
component of Bactrim
component of Septra
nchembio.108-comp1
nchembio.215-comp11
nchembio.221-comp23
trimethoprim
5
AcetylcholineapprovedPhase 4, Phase 3, Phase 280551-84-3187
Synonyms:
ACh
Acetyl choline ion
Acetylcholine Chloride
Acetylcholine cation
 
Acetylcholinium: acetyl-Choline
Choline acetate
Choline acetate (ester)
O-Acetylcholine
acetylcholine chloride
6
Amoxicillinapproved, vet_approvedPhase 446526787-78-033613, 2171
Synonyms:
(-)-6-(2-Amino-2-(P-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo-(3.2.0)heptane-2-carboxylic acid
(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
26787-78-0
33911-69-2
34642-77-8 (mono-hydrochloride salt)
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-amino-2-(p-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-, D- (8CI)
6-(D-(-)-alpha-Amino-p-hydroxyphenylacetamido)penicillanic acid
6-(D-(-)-p-Hydroxy-alpha-aminobenzyl)penicillin
6-(a-Amino-4-hydroxyphenylacetamido)penicillanic acid
6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanic acid
6-(p-hydroxy-α-aminophenylacetamido)penicillanic acid
6-[[Amino(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 9CI
61336-70-7 (TRIHYDRATE)
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carbonyl
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carboxylic acid
71447-36-4
81030-75-3
AC-12263
AC1L1PY2
AMC
AMOXICILLIN CRYSTALLINE
AMOXICILLIN PEDIATRIC
AMPC
AUGMENTIN '125'
AUGMENTIN '200'
AUGMENTIN '250'
AUGMENTIN '400'
AUGMENTIN '500'
AUGMENTIN '875'
AUGMENTIN ES-600
AX
Actimoxi
Almodan
Ambap26787-78-0
Amix
Amoclen
Amolin
Amopen
Amopenixin
Amoram
Amox
Amox 250 Cap 250mg
Amox 500 Cap 500mg
Amox S 125 Sus 125mg/5ml
Amox S 250 Sus 250mg/5ml
Amoxi
Amoxi-Mast
Amoxi-mast
Amoxibiotic
Amoxicaps
Amoxicilina
Amoxicilina [INN-Spanish]
Amoxicillin (INN)
Amoxicillin (TN)
Amoxicillin (anhydrous)
Amoxicillin (inn)
Amoxicillin Trihydrate
Amoxicillin and clavulanate potassium
Amoxicillin anhydrous
Amoxicillin pediatric
Amoxicillin trihydrate
Amoxicillin(usan)
Amoxicilline
Amoxicilline [INN-French]
Amoxicilline [INN]
Amoxicilline [inn]
Amoxicillinum
Amoxicillinum [INN-Latin]
Amoxid
Amoxiden
Amoxil
Amoxivet
Amoxycillin
Amoxycillin Trihydrate
Amoxycillin trihydrate
Amoxycillin, BAN
Amoxymed
Amrit
Anemolin
Apo-Amoxi
Apo-Amoxi Cap 250mg
Apo-Amoxi Cap 500mg
Apo-Amoxi Pwr for Susp 125mg/5ml
Apo-Amoxi Pwr for Susp 250mg/5ml
Apo-amoxi
Apo-amoxi sugar free
Aspenil
BL-P 1410
BLP 1410
BPBio1_000499
BRD-K55044200-001-03-9
BRL 2333
BRL-2333
BSPBio_000453
 
Biomox
Bristamox
C06827
CHEBI:2676
CHEBI:53712
CHEMBL1082
CID33613
CPD000058707
Cemoxin
Clamoxyl
Clamoxyl (SKB)
D-(-)-alpha-Amino-p-hydroxybenzyl penicillin
D-(-)-alpha-Amino-p-hydroxybenzylpenicillin
D-(alpha-Amino-p-hydroxybenzyl)penicillin
D-2-Amino-2-(4-hydroxyphenyl)acetamidopenicillanic acid
D-Amoxicillin
D07452
DB01060
Delacillin
DisperMox
Dispermox
EINECS 248-003-8
Efpenix
Flemoxin
Galenamox
Gen-Amoxicillin 250mg
Gen-Amoxicillin 500mg
HMS1569G15
HSDB 3204
Hiconcil
Histocillin
Hydroxyampicillin
Ibiamox
Imacillin
LS-149721
Lamoxy
Larotid
MLS000028632
MLS002222248
Metafarma capsules
Metifarma capsules
MolPort-003-981-182
MolPort-005-933-687
Moxacin
Moxal
Moxatag
NCGC00179554-01
NSC 277174
NSC277174
Novamoxin Cap 250mg
Novamoxin Cap 500mg
Novamoxin Sus 125mg/5ml
Novamoxin Sus 250mg/5ml
Nu-Amoxi Cap 250mg
Nu-Amoxi Cap 500mg
Nu-Amoxi Sus 125/5ml
Nu-Amoxi Sus 250mg/5ml
Ospamox
P-Hydroxyampicillin
PHL-amoxicillin
PMS-amoxicillin
Pamoxicillin
Piramox
Polymox
Prestwick0_000357
Prestwick1_000357
Prestwick2_000357
Prestwick3_000357
Prestwick_713
Prevpac
Pro Amox Pwr for Oral Susp 125mg/5ml
Pro Amox-250 Cap 250mg
Pro Amox-500 Cap 500mg
Pro-Amox-250 Orl Sus 250mg/5ml
R-Hydroxyampicillin
Rimoxallin
Ro 10-8756
Robamox
SAM002264592
SMR000058707
SPBio_002374
Sauracillin
Sawamox PM
Sumox
Tolodina
Trimox
Unicillin
Utimox
Vetramox
Wymox
Zimox
alpha-Amino-p-hydroxybenzylpenicillin
amoxicillanyl
amoxicillin
p-Hydroxyampicillin
α-amino-p-hydroxybenzylpenicillin
7
CefiximeapprovedPhase 42279350-37-154362, 5362065
Synonyms:
(-)-Cefixim
(6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetyl}amino)-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethyloxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(carboxymethyl)oxy]imino}acetyl]amino}-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6r,7r)-7-[-2-(2-amino-thiazol-4-yl)-2-carboxymethoxyimino-acetylamino]-8-oxo-3-vinyl-5-thia-1-aza-b
79350-37-1
7beta-{(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido}-3-ethenyl-3,4-didehydrocepham-4-carboxylic acid
AB00513842
AC-4350
AC1NSFNI
BPBio1_000622
BRD-K71059170-001-02-5
BSPBio_000564
C06881
CEFIXIME
CFIX
CHEBI:472657
CHEBI:530642
CHEMBL1541
CID5362065
 
CL-284635
Cefixim
Cefixima
Cefixima [Spanish]
Cefixime (JP15/USP/INN)
Cefixime Anhydrous
Cefiximum
Cefiximum [Latin]
Céfixime
D00258
Denvar
FK-027
FR-17027
LS-187248
MLS002222332
MolPort-003-845-687
NCGC00179521-01
Necopen
Prestwick3_000462
SMR001307271
Suprax (TN)
Tricef
8
FosfomycinapprovedPhase 43423155-02-4446987
Synonyms:
(−
(-)-(1R,2S)-(1,2-Epoxypropyl)phosphonic acid
(1R,2S)(-)-(1,2-Epoxypropyl)phosphonic acid disodium salt
(1R,2S)-Epoxypropylphosphonic acid
(1R,2S)-epoxypropylphosphonate
(1R,2S)-epoxypropylphosphonic acid
(2R-cis)-(3-Methyloxiranyl)phosphonic acid
(2R-cis)-(3-Methyloxiranyl)phosphonic acid disodium salt
)-(1R,2S)-(1,2-Epoxypropyl)phosphonic acid
1R-cis-(1,2-Epoxypropyl)phosphonic acid
23155-02-4
26016-99-9
34089_FLUKA
34089_RIEDEL
6F066DFF-696A-4A94-AF78-A28430EBE5BA
AC1L2JXY
AC1L9KC0
AC1Q1URS
AR-1I6648
BIDD:GT0448
BRN 1680831, Fosfocina
C06454
CHEBI:681859
CHEMBL1757
CID446987
CID73491
CPD0-1113
D02188
D04253
DB00828
Disodium (1R,2S)-(1,2-epoxypropyl)phosphonate
Disodium fosfomycin
Disodium phosphonomycin
EINECS 247-409-2
FCM
FOM-Na
FOSFOMYCIN
 
Fosfocina
Fosfocina disodium salt
Fosfomicina
Fosfomycin (USAN/INN)
Fosfomycin disodium
Fosfomycin disodium salt
Fosfomycin sodium
Fosfomycin sodium (JP15)
Fosfomycin sodium salt
Fosfomycine
Fosfomycinum
Fosfonomycin
Fosmicin S
Fosmicin S (TN)
I06-1211
L-cis-1,2-Epoxypropylphosphonic acid
L-cis-1,2-epoxypropylphosphonic acid
LS-106593
MK 955
MolPort-003-847-502
NSC 136017
P5396_SIGMA
Phosphomycin
Phosphomycin disodium salt
Phosphonemycin
Phosphonic acid, (3-methyloxiranyl)-, disodium salt, (2R-cis)- (9CI)
Phosphonomycin
Phosphonomycin disodium salt
Phosphonomycin sodium
Priomicina
Sodium fosfomycin
Veramina
ZINC19594585
[(2R,3S)-3-methyloxiran-2-yl]phosphonic acid
cis-(1R,2S)-Epoxypropylphosphonic acid
disodium[(2r,3s)-3-methyloxiran-2-yl]phosphonate
nchem.1024-comp6
phosphomycin
9
Darifenacinapproved, investigationalPhase 4, Phase 222133099-04-4444031
Synonyms:
(S)-1-(2-(2,3-Dihydro-5-benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide
(S)-1-(2-(2,3-dihydro-5-Benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide
133099-04-4
2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide
2-{(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide
AC-302
AC1L9FKY
CHEBI:391960
CHEMBL1346
CID444031
D03654
 
DB00496
Darifenacin
Darifenacin (USAN/INN)
Darifenacina
Darifenacinum
Darifénacine
Emselex
Enablex
LS-187359
MolPort-005-943-011
NCGC00168775-01
STOCK6S-73577
darifenacin
10
TrospiumapprovedPhase 4, Phase 11810405-02-4, 47608-32-25596, 5284631
Synonyms:
10405-02-4
3-Hydroxyspiro(8-azoniabicyclo(3.2.1)octane-8,1'-pyrrolidinium) chloride benzilate
6,10-Ethano-5-azoniaspiro(4.5)decan-8-ol, chloride, benzilate
8-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride
AC1L1KP8
AC1L333K
AC1Q1SI9
AR-1L7894
CHEMBL1200605
CID107979
CID5596
D01103
DB00209
I06-0400
 
IP-631
L001322
LS-145788
MolPort-003-850-800
ST51052756
Spasmex
Spasmex (TN)
Spasmoplex
Spasmoplex (TN)
Spiro(8-azoniabicyclo(3.2.1)octane-8,1'-pyrrolidinium), 3-hydroxy-, chloride, benzilate
Trosec
Trospium
Trospium chloride (JAN/USAN/INN)
spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]-3-yl 2-hydroxy-2,2-diphenylacetate
spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]-3-yl 2-hydroxy-2,2-diphenylacetate chloride
trospium chloride
11
SilodosinapprovedPhase 423160970-54-7
Synonyms:
KAD 3213
 
KMD 3213
Rapaflo
Urief
12
Morphineapproved, investigationalPhase 4100757-27-25288826
Synonyms:
(-)(5.alpha.,6.alpha.)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(-)-Heroin hydrochloride
(-)-Morphine
(-)Morphine sulfate
(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol
(5R,6S,9R,13S,14R)-4,5-epoxy-N-methyl-7-morphinen-3,6-diol
(5alpha,6alpha)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol
(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(5alpha,6alpha)-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(5α,6α)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol
(5α,6α)-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A-HEXAHYDRO-1H-4,12-METHANO[1]BENZOFURO[3,2-E]ISOQUINOLINE-7,9-DIOL
(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol
(−)-morphine
17-methyl-7,8-didehydro-4,5alpha-epoxymorphinan-3,6alpha-diol
4,5alpha-Epoxy-17-methyl-7-morphinen-3,6alpha-diol
4-methyl-(13R,14S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol
47106-99-0
57-27-2
6211-15-0 (sulfate (2:1) (salt) pentahydrate)
64-31-3
64-31-3 (sulfate (2:1) (salt) anhydrous)
7,8-Didehydro-4,5-epoxy-17-methyl-morphinan-3,6-diol
7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
8053-16-5
85201-37-2
Apokyn
Astramorph PF
Avinza
BIDD:GT0147
C01516
CCRIS 5762
CHEBI:17303
CHEMBL70
CID5288826
Cube juice
D-(-)-Morphine
DB00295
DEA No. 9300
DepoDur
Depodur
Diacetylmorphine hydrochloride
Diamorphine hydrochloride
Dolcontin
Dreamer
Dulcontin
Duramorph PF
Duromorph
EINECS 200-320-2
Epimorph
HSDB 2134
Hard stuff
Heroin hydrochloride
Heroine hydrochloride
Hocus
 
Infumorph
Kadian
LS-91748
M-Eslon
M.O.S
MOI
MORPHINE SULFATE
MORPHINE, (5A,6A)-7,8-DIDEHYDRO-4,5-EPOXY-17-METHYLMORPHINIAN-3,6-DIOL, MORPHIUM, MORPHIA, DOLCONTIN, DUROMORPH, MORPHINA, NEPENTHE
MS Contin
MS/L
MS/S
MSIR
Meconium
MolPort-003-849-273
Morfina
Morfina [Italian]
Morphia
Morphin
Morphin [German]
Morphina
Morphina [Italian]
Morphine Extra-Forte
Morphine Forte
Morphine H.P
Morphine Sulfate
Morphine [BAN]
Morphinism
Morphinum
Morphitec
Morphium
Morpho
Moscontin
Ms Contin
Ms Emma
NSC11441
Nepenthe
O,O'-Diacetylmorphine hydrochloride
OMS Concentrate
Oramorph SR
Ospalivina
RMS
RMS Uniserts
Rescudose
Roxanol
Roxanol 100
Roxanol UD
SDZ 202-250
SDZ202-250
Statex
Statex Drops
Statex SR
UNII-76I7G6D29C
Unkie
l-Morphine
morfina
morphine
nchembio.317-comp1
nchembio.64-comp1
13Neurotransmitter AgentsPhase 4, Phase 3, Phase 2, Phase 118340
14Antitubercular AgentsPhase 4, Phase 1, Phase 21343
15Anti-Infective AgentsPhase 4, Phase 3, Phase 2, Phase 122062
16Neuromuscular AgentsPhase 4, Phase 3, Phase 21180
17incobotulinumtoxinAPhase 4, Phase 3, Phase 2662
18Botulinum ToxinsPhase 4, Phase 3, Phase 2697
19Renal AgentsPhase 4, Phase 3, Phase 1, Phase 2754
20Botulinum Toxins, Type APhase 4, Phase 3, Phase 2657
21Cholinergic AgentsPhase 4, Phase 3, Phase 2, Phase 13992
22Antibiotics, AntitubercularPhase 4, Phase 3, Phase 1, Phase 27180
23Anti-Bacterial AgentsPhase 4, Phase 3, Phase 1, Phase 211226
24Adrenergic AntagonistsPhase 4, Phase 2, Phase 3, Phase 11573
25Adrenergic alpha-AntagonistsPhase 4, Phase 2, Phase 3, Phase 1739
26Peripheral Nervous System AgentsPhase 4, Phase 3, Phase 2, Phase 123689
27Adrenergic alpha-1 Receptor AntagonistsPhase 4, Phase 2, Phase 3, Phase 1480
28AnestheticsPhase 4, Phase 39596
29Cholinergic AntagonistsPhase 4, Phase 3, Phase 2, Phase 11706
30onabotulinumtoxinAPhase 4, Phase 3, Phase 2652
31abobotulinumtoxinAPhase 4, Phase 3, Phase 2652
32Muscarinic AntagonistsPhase 4, Phase 3, Phase 2, Phase 11166
33Adrenergic AgentsPhase 4, Phase 2, Phase 3, Phase 15352
34BromidesPhase 4, Phase 1642
35Pharmaceutical SolutionsPhase 4, Phase 3, Phase 18192
36Autonomic AgentsPhase 4, Phase 3, Phase 2, Phase 110150
37AnticonvulsantsPhase 4, Phase 12695
38ParasympatholyticsPhase 4, Phase 3, Phase 11085
39Mandelic AcidsPhase 4, Phase 356
40Solifenacin succinatePhase 4, Phase 3, Phase 1116242478-38-2
41Clavulanic AcidPhase 4170
42Central Nervous System DepressantsPhase 4, Phase 313403
43AnalgesicsPhase 411733
44Analgesics, OpioidPhase 43238
45NarcoticsPhase 43646
46BelladonnaNutraceuticalPhase 45
47
Tamsulosinapproved, investigationalPhase 2, Phase 3, Phase 1159106133-20-4129211
Synonyms:
(R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide
106133-20-4
5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide
5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide
5-[(2R)-2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl]-2-methoxybenzenesulfonamide
5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide
5-[2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide
5-{(2R)-2-[(2-{[2-(ethyloxy)phenyl]oxy}ethyl)amino]propyl}-2-(methyloxy)benzenesulfonamide
AC1L2V76
BIDD:GT0261
C07124
C20H28N2O5S
CHEBI:9398
CHEMBL836
CID129211
D08560
DB00706
FT-0082894
Flomax
Flomax (TN)
Flowmax
HMS2090P15
 
Harnal
LS-31578
MolPort-003-850-388
NCGC00167442-01
Omnic
Pradif
STK626950
TAMSULOSIN
Tamsolusin
Tamsulon
Tamsulon (TN)
Tamsulosin
Tamsulosin (INN)
Tamsulosin [INN:BAN]
Tamsulosina
Tamsulosina [INN-Spanish]
Tamsulosine
Tamsulosine [INN-French]
Tamsulosinum
Tamsulosinum [INN-Latin]
UNII-G3P28OML5I
YM-617
tamsulosin
48
FesoterodineapprovedPhase 3, Phase 260286930-02-7, 286930-03-86918558
Synonyms:
FESO
 
Fesoterodine
Toviaz
49
OfloxacinapprovedPhase 323682419-36-14583
Synonyms:
( -)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazin-6-carbonsaeure
(+-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperaz inyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7- -oxo-7H-pyrido(1,2,3-de)- -1,4-benzoxazine-6-carboxylic acid
(+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
(+/-)-Floxin
118120-51-7 (hydrochloride)
33703_FLUKA
33703_RIEDEL
8-Fluoro-3-methyl-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylic acid
82419-36-1
83380-47-6
85344-55-4
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
AB00513820
AC-7616
AC1L1IHM
AKOS001033517
BB_SC-1252
BPBio1_000345
BRD-A24228527-001-05-9
BRN 3657947
BSPBio_000313
BSPBio_003117
Bactocin
C07321
C18H20FN3O4
CCRIS 5233
CHEBI:7731
CHEMBL4
CID4583
CPD000058192
D00453
DB01165
DEXTROFLOXACINE
DL 8280
DL-8280
DL-8280, HOE-280, Exocin, Flobacin, Floxin, Floxil, Monoflocet, Ofloxacin
Danoflox
DivK1c_000721
EU-0100904
Effexin
Exocin
Exocine
FLOXIN IN DEXTROSE 5%
FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Flobacin
Flodemex
Flotavid
Flovid
Floxal
Floxil
Floxin
Floxin (TN)
Floxin otic
Floxstat
Fugacin
HMS1568P15
HMS1921H12
HMS2090F07
HMS2092B10
HMS502E03
HOE 280
Hoe-280
I06-0112
I06-0380
IDI1_000721
Inoflox
KBio1_000721
KBio2_001666
KBio2_004234
KBio2_006802
KBio3_002617
KBioGR_000667
KBioSS_001666
Kinflocin
Kinoxacin
LS-133259
Liflox
Lopac0_000904
Loxinter
MLS000028749
MLS001074203
Marfloxacin
Medofloxine
Mergexin
MolPort-000-422-241
MolPort-000-873-068
NCGC00015772-02
NCGC00015772-10
 
NCGC00094219-01
NCGC00094219-02
NCGC00094219-03
NCGC00094219-04
NCGC00094219-05
NCGC00094219-06
NCGC00178284-01
NCGC00178284-02
NINDS_000721
NSC727071
Novecin
Nufafloqo
O 8757
O-Flox
O8757_SIGMA
OFLX
OFX
ORF 18489
ORF-28489
Obide
Occidal
Ocuflox
Ofcin
Oflin
Oflocee
Oflocet
Oflocin
Oflodal
Oflodex
Oflodura
Oflox
Ofloxacin (JP15/USP/INN)
Ofloxacin Otic
Ofloxacin [USAN:BAN:INN:JAN]
Ofloxacin, (S)-Isomer
Ofloxacina
Ofloxacina [DCIT]
Ofloxacine
Ofloxacine [French]
Ofloxacino
Ofloxacino [Spanish]
Ofloxacinum
Ofloxacinum [Latin]
Ofloxin
Ofus
Onexacin
Operan
Oprea1_242882
Orocin
Otonil
Oxaldin
PT 01
Pharflox
Praxin
Prestwick0_000237
Prestwick1_000237
Prestwick2_000237
Prestwick3_000237
Puiritol
Qinolon
Qipro
Quinolon
Quotavil
Rilox
Ru-43280
S1463_Selleck
SAM002264629
SMR000058192
SPBio_001387
SPBio_002234
SPECTRUM1502044
STK256723
Sinflo
Spectrum2_001464
Spectrum3_001499
Spectrum4_000324
Spectrum5_001063
Spectrum_001186
Tabrin
Taravid
Tariflox
Tarivid
Telbit
Tructum
UNII-A4P49JAZ9H
Uro Tarivid
Viotisone
Visiren
WP-0405
XED
Zanocin
ofloxacin
50
Levofloxacinapproved, investigationalPhase 3236100986-85-4149096
Synonyms:
(−
(-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(-)-(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyridol[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihydrate
(-)-(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7Hpyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihydrate
(-)-Ofloxacin
(3S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid
(3S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
(R)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(R)-isomer
(S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylic acid
(S)-(-)-Ofloxacin
(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(S)-Ofloxacin
)-Ofloxacin
100986-85-4
100986-86-5
28266_FLUKA
28266_SIGMA
AC-7593
AC1L3YF8
Aeroquin
Ambap100986-85-4
BRD-K09471561-001-06-7
BSPBio_002689
C07660
C18H20FN3O4
C18H20FN3O4.H2O
CCRIS 4073
CCRIS 4074
CHEMBL33
CID149096
CPD000466387
Cravit
Cravit (TN)
Cravit Ophthalmic
D08120
DB01137
DR 3354
DR-3355
DR-3355: L-isomer of ofloxacin
DR3355
Elequine
Floxacin
Floxel
Floxin
HMS1922J07
HMS2051G04
HMS2090O10
HMS2093E18
HR 355
HR-355
Iquix
KBio2_002199
KBio2_004767
KBio2_007335
KBio3_001909
 
KBioGR_001605
KBioSS_002199
L-Ofloxacin
L-ofloxacin
L0193
LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER
LEVOFLOXACIN
LFX
LS-133260
LS-171761
LVX
Leroxacin
Lesacin
Levaquin
Levofloxacin
Levofloxacin (INN)
Levofloxacin [USAN:INN:JAN]
Levofloxacin hydrate
Levofloxacin tablet, suspension or intravenous
Levofloxacine
Levofloxacine [INN-French]
Levofloxacino
Levofloxacino [INN-Spanish]
Levofloxacinum
Levofloxacinum [INN-Latin]
Levokacin
Levox
Levoxacin
MLS000759524
MLS001165709
MLS001423977
MP-376
MolPort-002-885-835
Mosardal
NCGC00178529-01
Nofaxin
Ofloxacin
Ofloxacin S-(-)-form
Oftaquix
Quixin
R-Ofloxacin
RWJ 25213-097
RWJ-25213
Reskuin
S-(-)-Ofloxacin
S1940_Selleck
SAM001246758
SMR000466387
SPBio_001891
SPECTRUM1504260
Spectrum2_001676
Spectrum3_000995
Spectrum4_001123
Spectrum5_001438
Spectrum_001719
Tavanic
Volequin
d-Levofloxacin

Interventional clinical trials:

(show top 50)    (show all 131)
idNameStatusNCT IDPhase
1Effect of Botulinum Toxin in Neurogenic Bladders in Children With MyelomeningoceleUnknown statusNCT00175123Phase 4
2Botox for Neurogenic Detrusor Overactivity and the Prevention of Autonomic Dysreflexia Following SCIUnknown statusNCT02298660Phase 4
3Botulinum A Toxin in the Treatment of Patients With Painful Bladder SyndromeUnknown statusNCT01157507Phase 4
4Efficacy and Safety of Silodosin on Voiding Dysfunction Associated With Neurogenic BladderCompletedNCT01228370Phase 4
5Safety and Efficacy of botulinumA Toxin (BotoxA) for Treatment of Neurogenic Bladder of Parkinson's DiseaseCompletedNCT01421719Phase 4
6Safety and Efficacy of a Weekly Oral Cyclic Antibiotic Programme in the Prevention of Urinary Tract Infection on Neurological BladderCompletedNCT01388413Phase 4
7Quality of Life Intermittent Catheter StudyCompletedNCT01523743Phase 4
8Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple SclerosisCompletedNCT00629642Phase 4
9A Study Evaluating Oxybutynin in Patients With Neurogenic Overactive Bladder Associated With a Neurological ConditionCompletedNCT00224029Phase 4
10Short and Long Term Exposure to Unique, Time-Varying Pulsed Electro-Magnetic Fields in Refractory Carpal Tunnel SyndromeCompletedNCT00277563Phase 4
11Onabotulinumtoxina Intradetrusorial Injections and NGF ExpressionCompletedNCT01629433Phase 4
12A Safety and Efficacy Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korean PatientsCompletedNCT02601287Phase 4
13Comparative Study of the Efficacy and Safety of Muscarinic M3 Receptors Antagonists in the Treatment of Neurogenic Detrusor OveractivityCompletedNCT00800462Phase 4
14Prevention of Bladder Dysfunction in Acute Spinal Cord InjuryRecruitingNCT01698138Phase 4
15Reduction of Bladder Injection Pain With Belladonna Opiate SuppositoryEnrolling by invitationNCT02600715Phase 4
16Safety and Efficacy Evaluation of Oxybutynin Topical Gel In Children With Neurogenic BladderSuspendedNCT01192568Phase 4
17Efficacy Study of Pudendal Neuromodulation for the Treatment of Neurogenic Overactive BladderTerminatedNCT01023269Phase 4
18Extended-Release Oxybutynin for the Treatment of Neurogenic Detrusor OveractivityTerminatedNCT01796548Phase 4
19Oral Omega-3 for Reduction of Kidney Scar Due to Pyelonephritis in ChildrenUnknown statusNCT02192580Phase 3
20L-carnitine on the Prevention of Renal Scarring in Acute PyelonephritisUnknown statusNCT02007889Phase 3
21Botox Versus Oxybutynin as First Line Treatment for the Poorly Compliant Pediatric Neurogenic BladderCompletedNCT01716624Phase 3
22Study to Evaluate the Efficacy and Safety of Tamsulosin in Children With Neurogenic BladderCompletedNCT00796614Phase 2, Phase 3
23Alfuzosin Treatment in Children and Adolescents With Neurogenic Urinary Bladder DysfunctionCompletedNCT00549939Phase 3
24Pharmacokinetics and Safety Study With Alfuzosin in Children and Adolescents With Elevated Detrusor Leak Point Pressure of Neuropathic EtiologyCompletedNCT00629720Phase 3
25Alfuzosin Treatment in Children and Adolescents With Hydronephrosis of Neuropathic EtiologyCompletedNCT00576823Phase 3
26Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS)CompletedNCT01600716Phase 3
27Efficacy and Tolerability of Propiverine Hydrochloride in Patients With Neurogenic Detrusor OveractivityCompletedNCT01530620Phase 3
28Use of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) DiseasesCompletedNCT01472263Phase 3
29Cranberry for Prevention of Urinary Tract Infections in Multiple Sclerosis PatientsCompletedNCT00280592Phase 3
30A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Complicated Urinary Tract InfectionsCompletedNCT00258089Phase 3
31Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive BladderCompletedNCT00461292Phase 3
32Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive BladderCompletedNCT00311376Phase 3
33A Clinical Study to Investigate How Solifenacin Fluid is Taken up, How Long it Stays in the Body and How Effective and Safe it is in Treating Children Aged From 6 Months to Less Than 5 Years With Symptoms of Neurogenic Detrusor Overactivity (NDO)CompletedNCT01981954Phase 3
34Intravesical Injection of Botulinum Toxin A Versus Saline for Neurogenic Detrusor OveractivityCompletedNCT01091727Phase 3
35A Study to Assess the Long Term Effect, Safety and Metabolism of a Solifenacin Liquid Suspension in Patients 5 to 18 Years of Age With Neurogenic Detrusor OveractivityCompletedNCT01565694Phase 3
36A Study To Find Out How Fesoterodine Works In Children Aged 6 To 17 Years With Bladder Overactivity Caused By A Neurological ConditionRecruitingNCT01557244Phase 3
37Open-label Long-term Extension Study of Fesoterodine in Japanese Subjects With Neurogenic Detrusor Overactivity.RecruitingNCT02501928Phase 3
38Transcutaneous Tibial Nerve Stimulation for Treating Neurogenic Lower Urinary Tract DysfunctionRecruitingNCT02859844Phase 3
39Efficacy and Safety Study of GSK1358820 in Japanese Patients With Urinary Incontinence Due to Neurogenic Detrusor OveractivityRecruitingNCT02849418Phase 3
40OnabotulinumtoxinA (onaBoNT-A) Versus Oral Oxybutynin ERRecruitingNCT01050114Phase 3
41Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 2RecruitingNCT02660359Phase 3
42Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1RecruitingNCT02660138Phase 3
43Children Toxine Botulinum Detrusor Injection in Neurogenic Vesical Hyperactivity Syndrom: Non Inferiority Multicenter Controlled Therapeutic Study Between Two Reported Weight's DosesRecruitingNCT02816151Phase 3
44Open-label Phase 3 Study With Mirabegron in Children From 3 to Less Than 18 Years of Age With Neurogenic Detrusor OveractivityRecruitingNCT02751931Phase 3
45Urodynamic and Clinical Efficacy of Mirabegron for Neurogenic Bladder PatientsEnrolling by invitationNCT02044510Phase 2, Phase 3
46A Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A in Patients With Overactive Bladder (OAB)Enrolling by invitationNCT02786407Phase 3
47Antiseptic-coated Intermittent Urinary CatheterNot yet recruitingNCT02697162Phase 2, Phase 3
48Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive BladderTerminatedNCT00439140Phase 3
49Can Probiotics be Used in the Prevention of Recurrent UTI in Paediatric Neurogenic BladderUnknown statusNCT02044965Phase 1, Phase 2
50Bacterial Properties With LoFric® Catheters During Clean Intermittent CatheterizationUnknown statusNCT01305681Phase 1, Phase 2

Search NIH Clinical Center for Neurogenic Bladder

Inferred drug relations via UMLS68/NDF-RT46:


Cochrane evidence based reviews: urinary bladder, neurogenic

Genetic Tests for Neurogenic Bladder

About this section

Genetic tests related to Neurogenic Bladder:

id Genetic test Affiliating Genes
1 Neurogenic Bladder27

Anatomical Context for Neurogenic Bladder

About this section

MalaCards organs/tissues related to Neurogenic Bladder:

36
Spinal cord, Testes, Prostate, Kidney, Colon, Brain, T cells

Publications for Neurogenic Bladder

About this section

Articles related to Neurogenic Bladder:

(show top 50)    (show all 614)
idTitleAuthorsYear
1
Applicability of botulinum toxin type A in paediatric neurogenic bladder management. (27748667)
2017
2
Correlating spinal cord injuries with neurogenic bladder pathophysiology. (28090756)
2017
3
A framework for transitioning patients from pediatric to adult health settings for patients with neurogenic bladder. (27276694)
2016
4
The Management of the Pediatric Neurogenic Bladder. (27610207)
2016
5
Button Cystostomy: Is it really a Safe and Effective Therapeutic Option in Paediatric Patients with Neurogenic Bladder? (27693876)
2016
6
Augmentation enterocystoplasty without reimplantation for patients with neurogenic bladder and vesicoureteral reflux. (27377846)
2016
7
Predictive Factors for Intermittent Self-catheterization in German and Brazilian Individuals With Spina Bifida and Neurogenic Bladder Dysfunction. (27556346)
2016
8
Effectiveness of intermittent urinary catheterization in patients with neurogenic bladder: a systematic review protocol. (28009670)
2016
9
Sacral nerve stimulation for neurogenic bladder. (26960284)
2016
10
Retrograde pyelonephritis and lumbar spondylitis as a result of Salmonella typhi in a typeA 2 diabetes patient with neurogenic bladder. (27330732)
2016
11
Preserved micturition after intradetrusor onabotulinumtoxinA injection for treatment of neurogenic bladder dysfunction in Parkinson's disease. (27596481)
2016
12
Management of neurogenic bladder in patients with multiple sclerosis. (27030526)
2016
13
Bladder wall thickness in the assessment of neurogenic bladder: a translational discussion of current clinical applications. (26889485)
2016
14
Retrospective clinic and urodynamic study in the neurogenic bladder dysfunction caused by human T cell lymphotrophic virus type 1 associated myelopathy/tropical spastic paraparesis (HAM/TSP). (26756420)
2016
15
Localized inhibition of P2X7R at the spinal cord injury site improves neurogenic bladder dysfunction by decreasing urothelial P2X3R expression in rats. (28039004)
2016
16
Remarkable Points for Urodynamic Studies in Neurogenic Bladder Management. (27461447)
2016
17
Chronic Kidney Disease in Neurogenic Bladder. (28035730)
2016
18
Bulbocavernosus Reflex Test for Diagnosis of Pudendal Nerve Injury in Female Patients with Diabetic Neurogenic Bladder. (28053822)
2016
19
Prospective evaluation of antibiotic treatment for urological procedure in patients presenting with neurogenic bladder. (27241225)
2016
20
Identifying and classifying quality of life tools for neurogenic bladder function after spinal cord injury: A systematic review. (27734771)
2016
21
Congenital causes of neurogenic bladder and the transition to adult care. (26904411)
2016
22
Patient reported outcome measures in neurogenic bladder. (26904409)
2016
23
Sacral agenesis and neurogenic bladder: Long-term outcomes of bladder and kidney function. (26897325)
2016
24
Combinational effects of muscarinic receptor inhibition and I^3-adrenoceptor stimulation on neurogenic bladder dysfunction in rats with spinal cord injury. (27367752)
2016
25
Retroaortic Variant of Reverse Horseshoe Kidney With Butterfly Vertebrae Presenting as Neurogenic Bladder. (27282812)
2016
26
Augmentation cystoplasty in neurogenic bladder. (27617312)
2016
27
Conditional Electrical Stimulation in Animal and Human Models for Neurogenic Bladder: Working Toward a Neuroprosthesis. (27920880)
2016
28
Not all neurogenic bladders are the same: a proposal for a new neurogenic bladder classification system. (26904408)
2016
29
Complications of untreated and ineffectively treated neurogenic bladder dysfunctions in children: our own practical classification. (27097940)
2016
30
The Factors That Affect Improvement of Neurogenic Bladder by Severe Lumbar Disc Herniation in Operation. (27799991)
2016
31
Neurogenic Bladder Repair Using Autologous Mesenchymal Stem Cells. (27656308)
2016
32
Re: Screening for Depression and Anxiety in Childhood Neurogenic Bladder Dysfunction. (26853031)
2016
33
Role of gabapentin and anticholinergics in management of neurogenic bladder after repair of spina bifida - a randomized controlled study. (27680597)
2016
34
Typical Value Ranges and Typical Signal Patterns in the Initial Cough in Patients With Neurogenic Bladder: Quality Control in Urodynamic Studies. (27706014)
2016
35
Do patients with neurogenic bladder treated with clean intermittentcatheterization need antibacterial prophylaxis? (27513418)
2016
36
An Evaluation of the Efficacy of Selective Alpha-Blockers in the Treatment of Children with Neurogenic Bladder Dysfunction-Preliminary Findings. (26999168)
2016
37
Neuromodulation in neurogenic bladder. (26904417)
2016
38
A 4-year prospective urological assessment of in utero Myelomeningocele repair: Does gestational age at birth play a role at later neurogenic bladder pattern? (27988193)
2016
39
Urodynamic and physiologic patterns associated with the common causes of neurogenic bladder in adults. (26904410)
2016
40
Urinary tract infection in the neurogenic bladder. (26904414)
2016
41
Medical management of neurogenic bladder with oral therapy. (26904412)
2016
42
Management options for sphincteric deficiency in adults with neurogenic bladder. (26904420)
2016
43
Barriers to transition in young adults with neurogenic bladder. (27270070)
2016
44
The role of botulinum toxin A in treating neurogenic bladder. (26904413)
2016
45
Barriers to transition in young adults with neurogenic bladder. (27524424)
2016
46
Spinal extradural arachnoid cyst: A rare cause of neurogenic bladder. (27365974)
2016
47
TAU focused issue on adult management of neurogenic bladder. (26904406)
2016
48
Importance of Neurogenic Bladder as a Cause of Drainage Failure. (27006442)
2016
49
Botulinum Toxin to Treat Neurogenic Bladder. (26866490)
2016
50
Comparison of different antibiotic protocols for asymptomatic bacteriuria in patients with neurogenic bladder treated with botulinum toxin A. (27765580)
2016

Variations for Neurogenic Bladder

About this section

Expression for genes affiliated with Neurogenic Bladder

About this section
Search GEO for disease gene expression data for Neurogenic Bladder.

Pathways for genes affiliated with Neurogenic Bladder

About this section

Pathways related to Neurogenic Bladder according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.5CHRM2, PIP5K1C
2
Show member pathways
9.5CHRM2, P2RX1, P2RX2

GO Terms for genes affiliated with Neurogenic Bladder

About this section

Cellular components related to Neurogenic Bladder according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1integral component of nuclear inner membraneGO:000563910.2P2RX1, P2RX2
2postsynapseGO:00987949.8P2RX1, P2RX2

Biological processes related to Neurogenic Bladder according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1excitatory postsynaptic potentialGO:006007910.2P2RX1, P2RX2
2purinergic nucleotide receptor signaling pathwayGO:003559010.2P2RX1, P2RX2
3regulation of smooth muscle contractionGO:000694010.1CHRM2, P2RX1
4response to ATPGO:00331989.8P2RX1, P2RX2

Molecular functions related to Neurogenic Bladder according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1extracellular ATP-gated cation channel activityGO:000493110.0P2RX1, P2RX2
2purinergic nucleotide receptor activityGO:00016149.8P2RX1, P2RX2

Sources for Neurogenic Bladder

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet